baber/WOPTO huggingface dataset:
Patent CA-2447290-A1 (CA)
Inventor: KASUGA TOSHIHIRO
IPC: H01M8/02
Filed: 2002-12-26
Abstract: A proton-conductive gel which has a high ionic conductivity at around room temperature, can be easily made to have a reduced thickness and an increased size, and is capable of imparting excellent suitability for practical use to products such as a fuel cell. The gel comprises a dispersed phase comprising molecular chains of a phosphoric acid salt and a dispersion medium comprisin g water.
Patent CA-2447918-A1 (CA)
Title: Method of treating dry eye disorders
Inventor: GAMACHE DANIEL A
IPC: A61P27/04
Filed: 2002-05-17
Abstract: 22,29-epoxy-3,4,6,7,29-pentahydroxy-,(3.alpha.,4.beta.,5.alpha.,6.alpha.,7.beta.,14.beta.,22S)-stigmastan-15-one is useful for treating dry eye disorders and other disorders requiring the wetting of the eye.
Patent CA-2449991-A1 (CA)
Title: Device for sow intra-uterine insemination and embryo transfer
Inventor: SIMMET LUDWIG O
IPC: A61D19/04
Filed: 2002-02-20
Abstract: An internal catheter has a flexible plastic inner tube with an integrally formed protruding head with an axial channel. The internal catheter extends through an axial channel in an exterior catheter. With the internal catheter head withdrawn within the foam or spiral tip of the exterior catheter, the assembly is advanced into a sow cervix, and the internal catheter is then advanced through the tip of the catheter and remaining portion of the cervix and into the uterine body and possible into a uterine born. Semen or embryos are then introduced through the axial cavity. The tip of the exterior catheter may have a protective flap which is not penetrated until the inner tube is advanced therethrough. The internal catheter axial channel may have a constricted portion within the head, to engage a semen or embryo containing straw.
Patent CA-2450859-A1 (CA)
Inventor: SULLIVAN DARIUS MARTIN
IPC: G06F3/033
Filed: 2002-07-03
Abstract: A contact sensitive device (10) comprising a member (12) capable of supporting bending waves, a first sensor (16) mounted on the member for measuring bending wave vibration in the member, the sensor (16) determining a first measured bending wave signal and a processor which calculates information relating to a contact on the member (12) from the measured bending wave signal, the processor applying a correction based on the dispersion relation of the material of the member (12) supporting the bending waves, characterised in that the device (10) comprises a second sensor (16) to determine a second measured bending wave signal which is measured simultaneously with the first measured bending wave signal and the processor calculates a dispersion corrected function of the two measured bending wave signals which is selected from the group consisting of a dispersion corrected correlation function, a dispersion corrected convolution function, a dispersion corrected coherence function and other phase equivalent functions to determine information relating to the contact.
Patent CA-2451922-A1 (CA)
Title: Method, computer program product and computer system for modifying roles that trigger application services
Inventor: VIETH THORSTEN
IPC: G06F15/00
Filed: 2002-03-15
Abstract: The present invention discloses a method, computer program product and system for adjusting roles in a computer system (100) that launch application services (301-307) by a first user who is assigned to at least one role. A  first role (110) calls a second role (150) by reference (111). Both roles comprise representations of applications services (101, 102, 103) and (104, 105). When representations in the second role are modified, for example, application services are added (106, 107), a delta list (112) for the first reference is automatically created to conditionally prevent the first role (110) from referencing to at least some of the modified representations of the second role (150). This is achieved by using a rule database (118) containing rules about application services that are mutually exclusive and checking for conflicts between the representations of the first role and modified, second role. A second user, e.g. a system administrator, can accept or reject automatically created delta entries (114) in the delta list (112).
Patent CA-2454853-A1 (CA)
Title: Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier
Inventor: KRANTZ MARK J
IPC: A61K49/00
Filed: 2002-08-05
Abstract: A conjugate of a plurality of carbohydrate haptens and an aggregate (multime r) of monomeric units of a carrier moiety is provided. The conjugate may be use d to elicit an immune response. The conjugate is preferably a carbohydrate- substituted aggregate of KLH monomers, in particular, a dimeric, trimeric or tetrameric aggregated. An aggregated STn-KLH conjugate is of particular interest.
Patent CA-2458311-A1 (CA)
Title: Thread rolling dies apparatus for a thread rolling machine
Inventor: YANG KUN-SAN
IPC: B21H9/02
Filed: 2004-02-20
Abstract: A thread rolling dies apparatus for a thread rolling machine discloses a positioning channel formed between a~ first and second dies, and using a sensitive member placed in the channel and lower than the top of the channel touches with an alert driving member to make the thread rolling machine stopped when the inclined head is generated. The thread rolling dies apparatus for a thread rolling machine could inspect the wasters after the head rolling process to effectively decrease the fail off rate and enhance the quality of the product.
Patent CA-2459520-A1 (CA)
Inventor: SHAW WAYNE
IPC: F16L59/02
Filed: 2002-09-06
Abstract: A fiber insulation product for use as, e.g., a ductliner, includes at least one textile fiber (3) layer laminated with at least one rotary (2) and/or flame attenuated fiber layer. The fiber laminate provides improved thermal a nd acoustic insulation and excellent strength, at a low production cost.</SDOAB >
Patent CA-2463481-A1 (CA)
Inventor: ROWE CHARLES W
IPC: A61K9/20
Filed: 2001-11-21
Abstract: The invention includes dispensing a suspension containing solid particles for use in manufacturing a dosage form or other biomedical article by 3DP. The suspension contains solid particles suspended in a liquid. The solid particles may be one or more Active Pharmaceutical Ingredients. The solid particles may be particles of material that are insoluble in the liquid, or they may be particles of a substance that have already dissolved in the liquid up to the saturation level and are present in a concentration beyond what can be dissolved. In addition to solid particles, the liquid may also contain other substances dissolved in it, either substances containing Active Pharmaceutical Ingredients (API) or substances without API. One aspect of the invention includes prevention of agglomeration by adding one or more of several categories of additives to the suspending liquid. Another aspect of the invention includes manipulating the surface charge of the particles in an API  suspension to prevent particles from agglomerating. A further aspect of the invention includes an amorphous API that has a greater bioavailability than the corresponding crystalline material. Yet another aspect of the present invention includes a system for providing continuous circulation of the suspension such that the solid particles remain dispersed in the suspension.
Patent CA-2465563-A1 (CA)
Title: Chassis for downhole drilling tool
Inventor: VILLAREAL STEVEN A
IPC: E21B47/01
Filed: 2004-04-29
Abstract: The present invention relates to a chassis for a downhole drilling tool. The chassis is positionable in a drill collar of a downhole tool and includes a first portion and a second portion. The first portion defines a passage for the flow of drilling fluid through the drill collar. The first portion is made of a high machinable material and has at least one cavity therein for housing instrumentation. The second portion is positioned about the first portion such that the first portion is isolated from the drilling fluid. The second portion is made of a high strength and/or an erosion resistant material. A HIP process may be used to metallurgically bond the materials together to from the chassis.
Patent CA-2465621-A1 (CA)
Title: Pharmaceutical compositions of atorvastatin
Inventor: BERCHIELLI ALFRED
IPC: A61K9/20
Filed: 2004-04-29
Abstract: A unit dosage form comprising atorvastatin or a pharmaceutically acceptable salt thereof, prepared without a granulation step, wherein the measured atorvastatin potency of said dosage form shows a relative standard deviation (RSD) for atorvastatin potency per unit dosage form of not more than about 7.8%, when said unit dosage form is prepared at a rate that greater than 10,000 unit dosage forms per hour per single unit dosage form per machine, as well as the unit dsoage form in combination with at least one active drug, methods for preparing unit dosage form, kits for containing such compositions and a method of treating hypercholesterolemia and/or hyperlipidemia, osteoporosis, benign prostatic hyperplasia (BPH), and Alzheimer's Disease using a therapeutically effective amount of the unit dosage form.
Patent CA-2466562-A1 (CA)
Title: Zero twist carrier
Inventor: GAUTIER ROBERT
IPC: F16H1/46
Filed: 2002-11-07
Abstract: A torque transfer assembly (12) adapted for use in a planetary gear train is provided. The torque transfer assembly (12) comprises generally a planetary carrier (42) and a torque transfer coupling adapter (44). The planetary carrier (44) is adapted to rotatably support the plurality of planet gears (38) between a first and second planes (48a, 48b). The planetary carrier (42) also has a first connecting member (50) extending therefrom. The torque transfer coupling adapter (44) is disposed concentrically and rotatably with the planetary carrier (42), and has a central torque output element (54) and a second connecting member (52) extending from it. The second connecting member (52) is adapted to be engaged with the first connecting member (50) to structurally join the coupling adapter (44) and the planetary carrier (42), the first and second connecting members (50, 52) being structurally joined together between the first and second planes (48a, 48b).
Patent CA-2467195-A1 (CA)
Inventor: HORAN REBECCA L
IPC: A61K35/12
Filed: 2002-11-15
Abstract: The present invention provides a novel silk-fiber-based matrix having a wire-rope geometry for use in producing a ligament or tendon, particularly an anterior cruciate ligament, ex-vivo for implantation into a recipient in need thereof. The invention further provides the novel silk-fiber-based matrix which is seeded with pluripotent cells that proliferate and differentiate on the matrix to form a ligament or tendon ex vivo. Also disclosed is a bioengineered ligament comprising the silk-fiber-based matrix seeded with pluripotent cells that proliferate and differentiate on the matrix to form the ligament or tendon. A method for producing a ligament or tendon ex vivo comprising the novel silk-fiber-based matrix is also disclosed.
Patent CA-2467505-A1 (CA)
Inventor: HERSHBERGER CHARLES LEE
IPC: C12N9/12
Filed: 2002-12-03
Abstract: L'invention concerne un système d'expression qui permet de produire une protéine cible dans une cellule hôte comprenant un gène à intégration homologue codant pour une polymérase ARN T7, et un gène non intégré codant pour une protéine cible.
Patent CA-2468500-A1 (CA)
Title: Procede d'oxydation dans un reacteur a lit fluidise
Inventor: FIORENTINO MICHELE
IPC: C07C69/145
Filed: 2002-11-29
Abstract: L'invention concerne un procédé consistant à faire réagir dans un réacteur à lit fluidisé au moins un réactif oxydable avec de l'oxygène moléculaire en présence d'un lit fluidisé de particules solides, actif d'un point de vue catalytique. Dans le procédé, un gaz contenant de l'oxygène moléculaire et qui présente une concentration d'oxygène supérieure à celle de l'air est introduit dans le lit fluidisé pendant que celui-ci est maintenu dans un régime turbulent. Ce procédé convient pour des procédés d'oxydation, d'ammoxydation et de carboxylation, y compris la production d'anhydride maléique, d'acrylonitrile, d'éthylène, d'acide acétique et d'acétate de vinyle.
Patent CA-2473322-A1 (CA)
Title: Device for raising or cultivating cells in a container-like receptacle
Inventor: BADER AUGUSTINUS
IPC: C12M3/00
Filed: 2003-01-11
Abstract: A device for raising or cultivating cells in a container-like receptacle, comprises a base and at least one lid. The at least one lid is connected to the receptacle in a pressure--tight manner. The receptacle or the lid is provided with at least one connector drilling for the introduction and/or extraction of culture medium and/or oxygen.
Patent CA-2479902-A1 (CA)
Title: Toothbrush assembly
Inventor: SPROSTA AL
IPC: A63H33/40
Filed: 2003-03-31
Abstract: A child's toothbrush includes a handle in the form of a toy, such as a rocket or a vehicle, and contains a removable vehicle, figurine, other toy or sundry product therein, and wherein the toothbrush head may be detachable from the handle.
Patent CA-2483141-A1 (CA)
Title: Novel trifluoromethylepinephrine compounds and methods of making and using thereof
Inventor: AMMANN JEFFREY R
IPC: C07C233/18
Filed: 2003-02-28
Abstract: Disclosed herein are trifluoromethylepinephrine compounds having the followi ng structural formula (I) wherein R1-R5 are each independently selected from th e group consisting of H, alkyl, alkoxyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, acyl, thioacyl, sulfonyl mercapto, alkylthio, carboxy, amino, alkylamino dialkylamino, carbamoyl, arylthio, and heteroarylthio; wherein X, Y, and Z are each independently selected from the group consistin g of H or trifluoromethyl with the proviso that at least one of which is trifluoromethyl. Also disclosed are pharmaceutical compositions comprising t he trifluoromethylepinephrine compounds and methods of making and using thereof . Novel trifluoroepinephrine intermediates are also disclosed.
Patent CA-2483899-A1 (CA)
Inventor: UCHIMI HIDEKI
IPC: C08J3/22
Filed: 2004-04-28
Abstract: L'invention concerne un mélange maître de pastilles constitué d'un mélange d'un groupe de mélange maître à densité relative élevée (A) présentant une densité relative comprise entre 1,8 et 3,5, et d'un groupe de mélange maître à faible densité relative (B) présentant une densité relative comprise entre 0,5 et 1,6. Le groupe de mélange maître (A) est composé de m types de pastilles cylindriques présentant des densités relatives différentes. Le groupe de mélange maître (B) est composé de n types de pastilles cylindriques présentant des densités relatives différentes, le groupe de mélange maître (A) et le groupe de mélange maître (B) satisfaisant la formule (1) suivante.
Patent CA-2484869-A1 (CA)
Title: Medium for contrast enhancement or convenience for ultrasonic, endoscopic, and other medical examinations
Inventor: DE ZIEGLER DOMINIQUE
IPC: A61K49/22
Filed: 2003-05-08
Abstract: The present invention relates to a particularly convenient medium for providing contrast enhancement and/or distension of the subject body or orga n cavity during imaging, radiographic, visualization, or other similar medical examinations, including ultrasound, endoscopic examinations, MRI, x-ray, hystero-salpingograms, CT scans, and similar procedures. The present inventi on provides the contrast enhancement and/or distends the body or organ cavity without constant leakage of the medium or the resulting need to constantly o r repeatedly infuse additional medium. The medium is designed to have sufficie nt viscosity or consistence initially - whether as a solid, semi-solid, gel, viscous fluid, or otherwise - to remain in the body or organ cavity for a ti me generally sufficient to complete the procedure, and then to facilitate easy removal or expulsion from the cavity, preferably by liquefying or losing viscosity. For imaging and radiographic examinations, the medium may provide enhanced contrast as well as the distension of the cavity. For visualization examinations, the medium typically would be optically transparent but provid e the convenient reliable distension. The phase or viscosity change may be triggered by a variety factors, such as the passage of time, a change in temperature or pH, the addition of another substance, or any other trigger that liquefies or otherwise facilitates easy removal or expulsion of the composition from the cavity.
Patent CA-2488590-A1 (CA)
Title: Ink ribbon cartridge
Inventor: YAMAMOTO HIDEKI
IPC: B41J17/32
Filed: 2004-11-30
Abstract: An ink ribbon cartridge including a frame, supply shaft supporting members and take-up shaft supporting members is provided. The supply shaft supporting members support a supply shaft, and the take-up shaft supporting members support a take-up shaft. The frame includes a first bearing member, a second bearing member, a front connecting member, which connects front ends of the first and second beating members together, and a back connecting member connects back ends of the first and second bearing members together. At least one of the front connecting member and the back connecting member has one of a groove or a hole capable of accommodating a portion of an image forming device in which the ink ribbon cartridge may be installed.
Patent CA-2488633-A1 (CA)
Inventor: KRIZ DARIO
IPC: C12N15/87
Filed: 2003-06-06
Abstract: The present invention relates to a device for membrane passage, which comprises at least two magnetic fields generating means, each of which can generate an alternating magnetic field in a spatially limited area located in or in the immediate vicinity of said means, and a separate sample containing membrane-enveloped biological material in each spatially limited area, said device being further connected to a computer program which controls the magnetic field generating means with respect to point of time and duration for activating each individual means.
Patent CA-2489155-A1 (CA)
Inventor: ANDERSON ALBERT GORDON
IPC: C08G18/80
Filed: 2003-07-02
Abstract: An improved aqueous cathodic electrocoating composition having a binder of a n epoxy-amine adduct and a polyisocyanate crosslinking agent; wherein the improvement is the use of a polyisocyanate crosslinking agent having at leas t one crosslinkable morpholine dione group per molecule. Electrodeposited finishes are formed that have reduced volatile emissions and film weight los s when heated to cure.
Patent CA-2490034-A1 (CA)
Title: Method and apparatus for a blow-molded collapsible container for dispensing liquids
Inventor: THARMAPURAM SRIRAM R
IPC: B29K105/26
Filed: 2004-12-10
Abstract: A seamless collapsible container has a molded finish, configured and adapted for sealing with a closure and, optionally, for attachment to a dispensing apparatus, and a seamless, blow molded body portion, comprising an inner surface, an outer surface, and a wall, where the wall is sufficiently thin to allow the body portion to collapse, and the molded finish and at least an inner layer of the body portion together comprise a seamless, single piece of thermoplastic material.  The seamless collapsible container may be used in such applications as a bag-in-box, a carton liner, and a beverage pouch.
Patent CA-2490955-A1 (CA)
Title: Multi purpose eyeglass device
Inventor: IFERGAN THIERRY
IPC: G02C9/00
Filed: 2004-12-20
Abstract: A pair of spectacles includes a main frame having a magnetic bridge piece. An auxiliary inner frame is secured by a magnetic member to the bridge piece and an outer auxiliary lens is similarly secured by a magnet to the bridge piece and at lateral locations onto edges of the main frame. The auxiliary outer lens is secured by a magnetic button which is inserted through an aperture in the outer lens and has a magnetic member an a head which is sized to overly the aperture. The magnetic member embedded in the button attracts the magnetic bridge piece thereby attaching the button to the main frame, the head overlies the aperture and secures the outer frame to the main frame.
Patent CA-2491673-A1 (CA)
Title: Synthese de naphtalimides, y compris d'amonafides, et preparations pharmaceutiques les contenant
Inventor: BROWN DENNIS M
IPC: A61K9/08
Filed: 2003-07-08
Abstract: La présente invention concerne des nouveaux procédés de synthèse de naphtalimides et d'analogues de mitonafide, ainsi que des sels desdites substances. Elle concerne également de nouvelles compositions, dont des naphtalimides et des sels de naphtalimide, et des analogues de ces substances, ainsi que des formes posologiques liquides stables desdites substances.
Patent CA-2492210-A1 (CA)
Inventor: KYLE DONALD J
IPC: A61P25/00
Filed: 2003-07-31
Abstract: This invention relates to aryl substituted hydantoins of Formula (I) or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein n, A, A', R, R1 and R2, are defined in the specification. The invention is also directed to the use of compounds of Formula (I) for the treatment of neurona l damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), an d for the treatment, prevention or amelioration of both acute or chronic pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.
Patent CA-2495406-A1 (CA)
Title: A method of immunomodulation using anti-cd83 antibodies
Inventor: KATO MASATO
IPC: A61P37/06
Filed: 2003-08-15
Abstract: The present invention relates generally to a method for modulating the activity of cells of the immune system, including stimulator and responder cells and to agents useful therefor. More particularly, the present inventio n relates to a method for preventing or down-regulating one or more functional activities of stimulator and responder cells such as, respectively, antigen- presenting cells and lymphocytes inter alia. The present invention further provides antibodies, which interact specifically with epitopes present on th e surface of antigen-presenting cells and lymphocytes, resulting in depletion, down-regulation or destruction of targeted antigen-presenting cells and lymphocytes in vivo or in vitro. The instant invention further provides a method for modulating an immune response in a subject and, in particular, fo r down-regulating the immuno-activity of an allogeneic immuno-competent graft and/or the immune response of a recipient of a solid organ transplant. The ability to modulate stimulator and responder cell immuno-activity may be useful, inter alia, in a range of immuno-therapeutic and immuno-prophylactic treatments that benefit from immune suppression.
Patent CA-2495793-A1 (CA)
Inventor: STAWSKI BARBARA
IPC: A23L27/00
Filed: 2003-08-26
Abstract: L'invention concerne des produits utilisables par voie orale, contenant de l'essence de cardamome, pour purification buccale, purification de l'haleine, avec effets bénéfiques antimicrobiens. On mentionne comme produits applicables oralement selon l'invention : les chewing gums, confiseries, bains de bouche, pulvérisations buccales et produits en films minces comestibles. En quantités efficaces, l'essence de cardamome est fournie dans un produit buccal en vue de permettre avantageusement la purification buccale et la purification de l'haleine.